Each year, as Americans roll up their sleeves for their annual flu shot, they might be surprised to learn their protection ...

Flu vaccines are crucial tools in protecting public health by reducing the risk of influenza illness and its complications.

The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

Cuts to funding and personnel at the US Centers for Disease Control and Prevention are endangering the public’s health and ...

The mRNA platform offers the advantage of faster vaccine production, which could allow more time to decide on which flu strains to cover.

For people younger than 65, U.S.-licensed flu vaccines had an estimated effectiveness of 44% to 54% that season. Among those who completed a 6-month follow-up, the mRNA vaccine had a relative efficacy ...

The global cell culture media market size is expected to reach USD 12.80 billion by 2033, registering a CAGR of 13.20% from 2025 to 2033, according to a new report by Grand View Research, Inc. Cell ...

Vivaldi Biosciences Inc., a venture-backed company with operations at the Research Innovation Center at Colorado State University, has been issued a patent for its DeltaFLU universal influenza vaccine ...

Turkeys make up approximately 2% of the entire U.S. poultry inventory, but account for 24% of new cases in commercial and ...

Health secretary RFK Jr. wants other countries to ban the use of the preservative thimerosal in vaccines, despite research showing it is a safe ingredient.

Invivyd surged after Merck’s Cidara acquisition, but the read-through for IVVD is limited due to key differences. Learn why ...